References
- Bonnevie O. Peptic ulcer In Denmark. Scand J Gastroenterol 1980: 15: 164–74
- Meade TW, Arie TH, Brewis M, et al. Recent history of ischemic heart disease and duodenal ulcer In doctors Br Med J 1968: 3(620): 701–4
- Monson RR, Macmahon B. Peptic ulcer in Massachusetts physicians. N Engl J Med 1969: 281(1): 11–5
- Drury TF, Howie LJ. Prevalence of selected chronic digestive conditions, United States. 1975. Vital Health Stat (10)1979: 10(123): 1–55
- Grossman MI, Kurata JH, Rotter JI. et al. Peptic ulcer: new therapies, new diseases. Ann Intern Med 1981: 95(5): 609–27
- Domschke S, Domschke W. Gastroduodenal damage due to drugs, alcohol and smoking. Clin Gastroenterol 1984: 13(2): 405–36
- Conn HO, Blitzer BL. Nonassociation of adrenocorticosteroid therapy and peptic ulcer. N Engl J Med 1976: 294(9): 473–9
- Lewis GP, Jusko WJ, Graves L, et al. Prednisone side-effects and serum-protein levels: a collaborative study. Lancet 1971: 2(728): 778–80
- Fielding JE. Smoking: health effects and control. N Engl J Med 1985: 313(8): 491–8: 313(9): 555–61
- Harrison AR, Elashoff JD, Grossman MI. Smoking and health: a report to the Surgeon General. Washington. DC: Dept of Health, Education, and Welfare. 1979: 9.3–9.21: DHEW publication No. 79–50066
- Sontag S, Graham DT, Belsito A, et al. Cimetidine, cigarette smoking, and recurrence of duodenal ulcer. N Engl J Med 1984: 311(11): 689–93
- Lam SK. Pathogenesis and pathophysiology of duodenal ulcer. Clin Gastroenterol 1984: 13(2): 447–72
- Kurata JH, Haile BM. Epidemiology of peptic ulcer disease. Clin Gastroenterol 1984: 13(2): 289–307
- Cotton PB, Shorvon PJ. Analysis of endoscopy and radiography in the diagnosis, follow-up and treatment of peptic ulcer disease. Clin Gastroenterol 1984: 13(2): 383–403
- Legerton CW Jr. Duodenal and gastric ulcer healing rates: a review. Am J Med 1984: 77(Suppl 5B): 2–7
- Marks IN, Samloff IM, eds. Third International Sucralfate Symposium. Peptic ulcer disease and gastritis: a worldwide review. Lisbon. Portugal: 1984 Sep 17. Am J Med 1985: 79(Suppl 2C): 1–64
- Robinson M. Review of peptic ulcer maintenance trials. Am J Med 1984: 77(Suppl 5B): 23–9
- Brogden RN, Heel RC, Speight TM, et al. Sucralfate: a review of Its pharmacodynamic properties and therapeutic use in peptic ulcer disease. Drugs 1984: 27(3): 194–209
- Garnett WR. Sucralfate: alternative therapy for peptic ulcer disease. Clin Pharm 1982: 1(4): 307–14
- Jensen DM. Health and economic aspects of peptic ulcer disease. Am J Med 1984: 77(Suppl 5B): 8–14
- Fordtran JS, Morawski SG. Richardson CT. In vivo and in vitro evaluation of liquid antacids. N Engl J Med 1973: 288(18): 923–8
- Ippoliti AF, Sturdevant RA, Isenberg JI, et al. Cimetidine versus intensive antacid therapy for duodenal ulcer: a multicenter trial. Gastroenterology 1978: 74(2 Pt 2): 393–5
- Drake D, Hollander D. Neutralizing capacity and cost effectiveness of antacids. Ann Intern Med 1981: 94(2): 215–7
- Zimmerman TW. Problems associated with medical treatment of peptic ulcer disease. Am J Med 1984: 77(Suppl 5B): 51–6
- Gibinski K, Rybicka J, Mikos E, et al. Doubleblind clinical trial on gastroduodenal ulcer healing with prostaglandin E2 analogues. Gut 1977: 18(8): 636–9
- Kollberg B, Slezak P. The effect of prostaglandin E? on duodenal ulcer healing. Prostaglandins 1982: 24(4): 527–36
- Vantrappen G, Janssens J, Popiela T, et al. Effect of 15(R)-15-methyl prostaglandin E2 (arbaprostil) on the healing of duodenal ulcer: a double-blind multicenter study. Gastroenterology 1982: 83(2): 357–63
- Freston JW, Forbes JA. A double-blind evaluation of the nocturnal antisecretory effects of anisotropine methylbromide in man: dose response and duration of action studies. J Clin Pharmacol 1977: 17(1): 29–36
- Barbara L, Belsasso E. Bianchi Porro G, et al. Pirenzepine in duodenal ulcer: a multicenter doubleblind controlled clinical trial. Scand J Gastroenterol (Suppl) 1979: 57: 17–9
- Mangla JG, Pereira M. Tricyclic antidepressants in the treatment of peptic ulcer disease. Arch Intern Med 1982: 142(2): 273–5
- Oselladore D, Chierichetti SM, Norberto L, et al. Pirenzepine (LS 519) in severe duodenal ulcer and in gastric ulcer: a double-blind clinical trial. Scand J Gastroenterol (Suppl) 1979: 57: 33–9